0.4901
-0.0099 (-1.98%)
-0.0099 (-1.98%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Heat Biologics Inc | HTBX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.50 | 0.4895 | 0.55 | 0.5264 | 0.50 | 00:00:05 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.48 | 0.5653 | 0.0853 | 15.09% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,336 | 3,650,665 | $ 0.5091497 | $ 1,858,735 | 25,383,428 | 0.1811 - 1.27 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:57 | formt | 1,337 | $ 0.4901 | USD |
Heat Biologics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 39.69M | 79.38M | $ -15.73M | -0.59 | - | 75.62M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 10.00 | 4.70% |
Heat Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HTBX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.599 | 0.6325 | 0.4895 | 0.545774 | 3,750,859 | -0.099 | -16.53% |
| 1 Month | 0.825 | 0.98 | 0.47 | 0.6293546 | 12,125,837 | -0.325 | -39.39% |
| 3 Months | 0.45 | 1.25 | 0.1811 | 0.7081129 | 13,535,583 | 0.05 | 11.11% |
| 6 Months | 0.47 | 1.25 | 0.1811 | 0.7013523 | 6,329,820 | 0.03 | 6.38% |
| 1 Year | 1.21 | 1.27 | 0.1811 | 0.7040302 | 3,337,940 | -0.71 | -58.68% |
| 3 Years | 8.60 | 8.80 | 0.1811 | 1.33 | 1,543,473 | -8.10 | -94.19% |
| 5 Years | 63.10 | 86.50 | 0.1811 | 4.76 | 1,264,044 | -62.60 | -99.21% |
Heat Biologics Description
| Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells that secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector. |
